BPMC - Blueprint Medicines EPS misses by $0.15 beats on revenue July, 30 2020 07:05 AM Blueprint Medicines Corporation Blueprint Medicines (NASDAQ:BPMC): Q2 GAAP EPS of -$2.28 misses by $0.15.More news on: Blueprint Medicines Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...